1 2

RETATRUTIDE | Reference Standard

$89.00
$89.00
Specification

    Product Details

    GLP-1 / GIP / Glucagon Receptor Signaling in Metabolic & Energy Homeostasis Research

    Category: Metabolic Signaling • Energy Expenditure • Obesity & Glucose Regulation Research


    What Researchers Study

    Retatrutide (LY3437943) is a next-generation synthetic peptide designed to simultaneously activate:

    • GLP-1 receptors

    • GIP receptors

    • Glucagon receptors

    This triple-agonist profile allows researchers to investigate coordinated regulation of appetite, insulin signaling, lipid mobilization, and energy expenditure within a single molecular framework.

    Unlike GLP-1 mono-agonists or dual agonists, Retatrutide uniquely enables parallel study of anabolic and catabolic signaling pathways that are normally difficult to isolate experimentally.

     

    Primary Signal Pathways Studied

    • GLP-1 receptor (GLP-1R): Satiety signaling, insulin secretion, gastric emptying

    • GIP receptor (GIPR): Nutrient partitioning, insulin sensitivity modulation

    • Glucagon receptor (GCGR): Lipolysis, hepatic glucose output, thermogenesis

    • Central–peripheral metabolic integration

    • Lean mass preservation during caloric deficit

     

    Why This Molecule Is Studied

    Researchers focus on Retatrutide because it allows:

    • Simultaneous interrogation of incretin + glucagon biology

    • Study of energy expenditure independent of caloric intake

    • Modeling of visceral fat reduction vs lean mass retention

    • Exploration of metabolic flexibility under chronic signaling

    It represents a systems-level metabolic probe, rather than a single-axis appetite modulator.

     

    Mechanistic Overview

    Retatrutide binds three metabolically critical GPCRs with balanced affinity:

    • GLP-1R activation enhances insulin secretion and satiety signaling

    • GIPR modulation improves post-prandial glucose handling and lipid distribution

    • GCGR activation increases hepatic fat oxidation and basal energy expenditure

    The combined signaling profile produces coordinated metabolic remodeling, making Retatrutide particularly valuable in longitudinal metabolic models.

     

    Key Research Domains

    1. Obesity & Body Composition Research

    Used to study:

    • Visceral vs subcutaneous fat dynamics

    • Appetite-independent weight reduction

    • Lean mass preservation under caloric restriction

    Frequently paired with:

    • DEXA or MRI body composition analysis

    • Automated food intake monitoring

    • Adipose tissue histology

    2. Glucose Homeostasis & Insulin Sensitivity

    Common endpoints include:

    • Fasting glucose and insulin levels

    • HOMA-IR and clamp studies

    • Pancreatic β-cell signaling dynamics

    Allows differentiation between insulin secretion effects and peripheral glucose utilization.

    3. Hepatic Lipid & NAFLD Models

    Studied for:

    • Hepatic triglyceride reduction

    • Glycogen storage modulation

    • Lipid oxidation vs storage balance

    Often combined with:

    • Liver histopathology

    • Triglyceride quantification

    • Gene expression analysis (PPARα, CPT-1, ACC)

    4. Cardiometabolic & Energy Expenditure Research

    Supports investigation of:

    • Resting energy expenditure

    • Thermogenic signaling

    • Autonomic metabolic regulation

    Compatible with:

    • Indirect calorimetry

    • Telemetry-based cardiovascular monitoring

    • Vascular reactivity assays

     

    Product Specifications

    • Compound Name: Retatrutide (LY3437943)

    • CAS Number: 2381089-83-2

    • Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈

    • Molecular Weight: 4731.33 Da 

    • Amino Acid Sequence: 

      Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{MeLeu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu}-(AEEA)-Ala-Gln-{Leu-Me}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

    • Peptide Class: GLP-1 / GIP / Glucagon triple-agonist
    • Purity: ≥98% (HPLC verified)
    • Form: Lyophilized powder

    • Appearance: White to off-white solid

    • Storage: ≤ –20 °C, desiccated, protected from light

     

    Batch Documentation & Traceability

    Each vial is shipped with a lot-specific QR code that provides secure access to batch documentation, including:

    • Certificate of Analysis (COA)
    • Identity verification report (HPLC / MS)
    • Lot number, potency, and expiration

    Documentation is locked to the specific batch shipped to ensure traceability, version control, and research reproducibility.

    QR access is provided with the physical product and is not reused across lots.

     

    Research Use Disclaimer

    This compound is supplied exclusively for laboratory research use.
    Not for human or veterinary use.
    Not for diagnostic, therapeutic, or consumptive applications.